# CABOMETYX
> **NDA208692** · New Drug Application · Sponsor: EXELIXIS INC · Approved 2016-04-25
## Drug
- **FDA Application Number:** NDA208692
- **Application type:** New Drug Application
- **Brand name:** CABOMETYX
- **Generic name:** CABOZANTINIB
- **Active ingredients:** CABOZANTINIB S-MALATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EXELIXIS INC
- **Manufacturer:** Exelixis, Inc.
- **First approval:** 2016-04-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208692)
---
*MORVS · CC0 1.0*